Zejula – Niraparib uses, dose and side effects
Zejula contains the active substance niraparib. Niraparib is a type of cancer drug called a PARP inhibitor. PARP inhibitors block an enzyme called PARP (poly[adenosine diphosphate‑ribose] polymerase). PARP helps cells repair damaged DNA . When niraparib blocks PARP, the DNA in the cancer cells cannot be repaired, leading to tumor cell death.
Read More